Interestingly, we noted a significant increase (~1.4-fold) in tumor uptake at all time points post-administration when a 100-fold excess of [NatCu]NOTA-C3-TP was co-injected with [64Cu]NOTA-C3-TP (Figure 7). The gene discussed is C3; the disease is neoplasm.